AusBioLabs sells BPC-157 only as a research chemical for qualified laboratory use
Fraenkel M, Ketzinel-Gilad M, Ariav Y, Pappo O, Karaca M, Castel J, Berthault MF, Magnan C, Cerasi E, Kaiser N, Leibowitz G (2008) mTOR inhibition by rapamycin prevents -cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes
That is not a claim from a fitness forum it is the conclusion of multiple randomized, placebo-controlled trials and the basis of an FDA approval
Perhaps most importantly, when you're nauseated or vomiting, keeping oral medications down can be nearly impossible